110
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Performance of Chromosomal Microarray Analysis for Detection of Copy Number Variations in Fetal Echogenic Bowel

, ORCID Icon, ORCID Icon, , ORCID Icon, & ORCID Icon show all
Pages 1431-1438 | Published online: 09 Apr 2021

References

  • Sepulveda W, Sebire NJ. Fetal echogenic bowel: a complex scenario. Ultrasound Obstet Gynecol. 2000;16(6):510–514. doi:10.1046/j.1469-0705.2000.00322.x
  • Maillet L, Rudigoz RC, Buffin R, Massardier J, Gaucherand P, Huissoud C. Neonatal outcome of fetal hyperechogenic bowel. Gynecol Obstet Fertil. 2014;42(6):383–386. doi:10.1016/j.gyobfe.2014.01.006
  • Kesrouani AK, Guibourdenche J, Muller F, et al. Etiology and outcome of fetal echogenic bowel. Ten years of experience. Fetal Diagn Ther. 2003;18(4):240–246. doi:10.1159/000070803
  • Findley R, Allen VM, Brock JK. Adverse perinatal conditions associated with prenatally detected fetal echogenic bowel in Nova Scotia. J Obstet Gynaecol Can. 2018;40(5):555–560. doi:10.1016/j.jogc.2017.09.017
  • D’Amico A, Buca D, Rizzo G, et al. Outcome of fetal echogenic bowel: a systematic review and meta-analysis. Prenat Diagn. 2020.
  • Bashiri A, Burstein E, Hershkowitz R, Mazor M. Fetal echogenic bowel by ultrasound: what is the clinical significance? Harefuah. 2007;146(12):964–969, 996–997.
  • Strocker AM, Snijders RJ, Carlson DE, et al. Fetal echogenic bowel: parameters to be considered in differential diagnosis. Ultrasound Obstet Gynecol. 2000;16(6):519–523. doi:10.1046/j.1469-0705.2000.00241.x
  • Ronin C, Mace P, Stenard F, et al. Antenatal prognostic factor of fetal echogenic bowel. Eur J Obstet Gynecol Reprod Biol. 2017;212:166–170. doi:10.1016/j.ejogrb.2017.01.060
  • Levy B, Wapner R. Prenatal diagnosis by chromosomal microarray analysis. Fertil Steril. 2018;109(2):201–212. doi:10.1016/j.fertnstert.2018.01.005
  • Stosic M, Levy B, Wapner R. The use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol Clin North Am. 2018;45(1):55–68. doi:10.1016/j.ogc.2017.10.002
  • Xie Y, Sun X. Chromosomal microarray analysis in prenatal diagnosis. Clin Exp Obstet Gynecol. 2017;44(2):177–179.
  • Wapner RJ, Martin CL, Levy B, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175–2184. doi:10.1056/NEJMoa1203382
  • Song T, Wan S, Li Y, et al. Detection of copy number variants using chromosomal microarray analysis for the prenatal diagnosis of congenital heart defects with normal karyotype. J Clin Lab Anal. 2019;33(1):e22630. doi:10.1002/jcla.22630
  • Patel Y, Boyd PA, Chamberlain P, Lakhoo K. Follow-up of children with isolated fetal echogenic bowel with particular reference to bowel-related symptoms. Prenat Diagn. 2004;24(1):35–37. doi:10.1002/pd.787
  • Ekin A, Gezer C, Taner CE, Ozeren M. The effect of associated structural malformations in the prediction of chromosomal abnormality risk of fetuses with echogenic bowel. J Matern Fetal Neonatal Med. 2016;29(1):41–45. doi:10.3109/14767058.2014.986091
  • Tan HH, Tan VC, Yeo GS. A case series of gastrointestinal abnormalities in fetuses with echogenic bowel detected during the antenatal period. Ann Acad Med Singap. 2003;32(5):649–652.
  • Imon-Bouy B, Satre V, Ferec C, et al.; French Collaborative Group. Hyperechogenic fetal bowel: a large French collaborative study of 682 cases. Am J Med Genet A. 2003;121A(3):209–213. doi:10.1002/ajmg.a.20168
  • Grijseels EW, Cohen-Overbeek TE, Adama van Scheltema PN, et al. Sonomarkers: subtle ultrasound findings in the 20-week ultrasound examination, which have a low association with some chromosomal and non-chromosomal abnormalities in the fetus. Ned Tijdschr Geneeskd. 2008;152(41):2225–2231.
  • Buiter HD, Holswilder-Olde Scholtenhuis MA, Bouman K, van Baren R, Bilardo CM, Bos AF. Outcome of infants presenting with echogenic bowel in the second trimester of pregnancy. Arch Dis Child Fetal Neonatal Ed. 2013;98(3):F256–F259. doi:10.1136/archdischild-2012-302017
  • Tang SY, Du J, Huang J, Ling HY, Meng DH. Prenatal diagnosis of fetal echogenic bowel and its clinical significance. Matern Child Health Care Chin. 2013;28(18):3015–3017.
  • Crawford D, Dearmun A. Klinefelter syndrome. Nurs Child Young People. 2017;29(6):19. doi:10.7748/ncyp.29.6.19.s21
  • Bird RJ, Hurren BJ. Anatomical and clinical aspects of Klinefelter’s syndrome. Clin Anat. 2016;29(5):606–619. doi:10.1002/ca.22695
  • Berlin BM, Norton ME, Sugarman EA, Tsipis JE, Allitto BA. Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel. Obstet Gynecol. 1999;94(1):135–138. doi:10.1016/s0029-7844(99)00286-0
  • Dagklis T, Plasencia W, Maiz N, Duarte L, Nicolaides KH. Choroid plexus cyst, intracardiac echogenic focus, hyperechogenic bowel and hydronephrosis in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks. Ultrasound Obstet Gynecol. 2008;31(2):132–135. doi:10.1002/uog.5224
  • Langer JC. Hirschsprung disease. Curr Opin Pediatr. 2013;25(3):368–374. doi:10.1097/MOP.0b013e328360c2a0
  • Wang XJ, Camilleri M. Hirschsprung disease: insights on genes, penetrance, and prenatal diagnosis. Neurogastroenterol Motil. 2019;31(11):e13732. doi:10.1111/nmo.13732
  • Wester T, Granström AL. Hirschsprung disease-bowel function beyond childhood. Semin Pediatr Surg. 2017;26(5):322–327. doi:10.1053/j.sempedsurg.2017.09.008
  • Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al.; Hirschsprung Disease Consortium. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45(1):1–14. doi:10.1136/jmg.2007.053959
  • de Kovel CG, Trucks H, Helbig I, et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain. 2010;133(Pt 1):23–32. doi:10.1093/brain/awp262
  • Smith AE, Jnah A, Newberry D. Chromosome 16p13.11 microdeletion syndrome in a newborn: a Case Study. Neonatal Netw. 2018;37(5):303–309. doi:10.1891/0730-0832.37.5.303
  • Tan L, Bi B, Zhao P, et al. Severe congenital microcephaly with 16p13.11 microdeletion combined with NDE1 mutation, a case report and literature review. BMC Med Genet. 2017;18(1):141. doi:10.1186/s12881-017-0501-9
  • Isselbacher EM, Lino Cardenas CL, Lindsay ME. Hereditary influence in thoracic aortic aneurysm and dissection. Circulation. 2016;133(24):2516–2528. doi:10.1161/CIRCULATIONAHA.116.009762
  • Takeda N, Morita H, Fujita D, et al. A deleterious MYH11 mutation causing familial thoracic aortic dissection. Hum Genome Var. 2015;2(1):15028. doi:10.1038/hgv.2015.28
  • Bradshaw NJ. Cloning of the promoter of NDE1, a gene implicated in psychiatric and neurodevelopmental disorders through copy number variation. Neuroscience. 2016;324:262–270. doi:10.1016/j.neuroscience.2016.03.018
  • Allach El Khattabi L, Heide S, Caberg JH, et al. 16p13.11 microduplication in 45 new patients: refined clinical significance and genotype-phenotype correlations. J Med Genet. 2020;57(5):301–307. doi:10.1136/jmedgenet-2018-105389
  • Scheuvens R, Begemann M, Soellner L, et al. Maternal uniparental disomy of chromosome 16 [upd(16)mat]: clinical features are rather caused by (hidden) trisomy 16 mosaicism than by upd(16)mat itself. Clin Genet. 2017;92(1):45–51. doi:10.1111/cge.12958
  • Wang H, Luo C, Liu Y, et al. UPD16 itself is not a cause of intrauterine growth restriction. Fetal Pediatr Pathol. 2018;37(6):452–464. doi:10.1080/15513815.2018.1538275
  • Yong PJ, Marion SA, Barrett IJ, Kalousek DK, Robinson WP. Evidence for imprinting on chromosome 16: the effect of uniparental disomy on the outcome of mosaic trisomy 16 pregnancies. Am J Med Genet. 2002;112(2):123–132. doi:10.1002/ajmg.10702
  • Desai P, Haber H, Bulafka J, et al. Impacts of variants of uncertain significance on parental perceptions of children after prenatal chromosome microarray testing. Prenat Diagn. 2018;38(10):740–747. doi:10.1002/pd.5323
  • Dugoff L, Norton ME, Kuller JA; Society for Maternal-Fetal Medicine (SMFM). The use of chromosomal microarray for prenatal diagnosis. Am J Obstet Gynecol. 2016;215(4):B2–B9. doi:10.1016/j.ajog.2016.07.016
  • Swarna M, Sujatha M, Rani PU, Reddy PP. Detection of L1 CAM mutation in a male child with mental retardation. Indian J Clin Biochem. 2004;19(2):163–167. doi:10.1007/BF02894278
  • Gonzales ML, LaSalle JM. The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep. 2010;12(2):127–134. doi:10.1007/s11920-010-0097-7
  • Kosma K, Mitrakos A, Sofokleous C, et al. A female patient with Xq28 microduplication presenting with myotubular myopathy, confirmed with a custom-designed X-array. Neuropediatrics. 2019;50(1):61–63. doi:10.1055/s-0038-1676513
  • Wang Y, Hu P, Xu Z. Copy number variations and fetal ventriculomegaly. Curr Opin Obstet Gynecol. 2018;30(2):104–110. doi:10.1097/GCO.0000000000000439
  • Hu P, Wang Y, Sun R, et al. Copy number variations with isolated fetal ventriculomegaly. Curr Mol Med. 2017;17(2):133–139. doi:10.2174/1566524017666170303125529